Overview


According to FutureWise analysis the market for Medical Fluid Bags in 2026 is US$ 4.47 billion, and is expected to reach US$ 8.11 billion by 2036 at a CAGR of 6.14%. This growth is driven by increasing demand for intravenous therapies, blood transfusions, and dialysis treatments across hospitals and outpatient care settings. Rising prevalence of chronic diseases, surgical procedures, and emergency care needs is further boosting usage. Additionally, advancements in bag materials, safety features, and eco-friendly designs are enhancing product reliability and adoption.

Medical fluid bags are vital healthcare products utilized for the storage, delivery, and administration of various fluids, including intravenous solutions, blood, plasma, dialysis fluids, and nutritional supplements. These bags are commonly found in hospitals, clinics, ambulatory surgical centers, and home healthcare settings, playing an essential role in patient hydration, medication delivery, transfusion therapy, and life-support treatments. Their design prioritizes safe, sterile, and controlled fluid transfer, making them crucial in contemporary medical practice.

Typically, medical fluid bags are manufactured from flexible, medical-grade materials such as polyvinyl chloride (PVC) or alternative non-PVC options. These materials are engineered to ensure biocompatibility, durability, and leak resistance. There has been a notable industry shift toward non-PVC and DEHP-free materials in response to safety concerns and regulatory guidelines. This transition helps minimize the risk of chemical leaching while maintaining characteristics such as clarity, strength, and compatibility with a variety of medical fluids and drugs.

Functionality and safety are key considerations in the design of medical fluid bags. Features like secure ports, tamper-evident seals, graduated markings, and compatibility with infusion sets facilitate accurate dosing and streamline clinical workflows. Additionally, specialized bags are available for specific medical applications, including blood bags equipped with anticoagulant systems, nutrition bags for parenteral feeding, and dialysis bags intended for renal therapies. These variations ensure optimal performance and patient safety in diverse treatment scenarios.

The growing prevalence of chronic diseases, an increase in surgical procedures, and a heightened demand for emergency and critical care services are driving the extensive use of medical fluid bags across the globe. Furthermore, the rise of home healthcare and outpatient treatment models is increasing the demand for user-friendly and reliable fluid delivery systems. Ongoing innovations aimed at enhancing sustainability, infection control, and smart monitoring features are shaping the future of medical fluid bags. This progress underscores their significance in improving patient outcomes, enhancing care efficiency, and addressing the evolving needs of global healthcare systems.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Medical Fluid Bags Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Medical Fluid Bags Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • B. Braun Medical
  • Baxter International
  • C.R. Bard (Becton, Dickinson and Company)
  • Coloplast
  • ConvaTec
  • Fresenius Kabi
  • Maco Pharma
  • Pall Corporation
  • Renolit
  • Smiths Medical
  • Technoflex
  • Terumo Corporation
  • Thermo Fisher Scientific

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Blood Bags
  • Intravenous Bags
  • Drain Bags
    • Surgical
    • Urinary
  • Enema Bags
  • Biohazard Disposable Bags
  • Breast Milk Bags
  • Reagent Bags
  • Dialysis Bags
  • Others

By Material

  • PVC Compounds
  • Polyolefins
  • Thermoplastic Elastomers
  • Thermoplastic Polyurethanes
  • Others

By End-Use

  • Hospital
  • Blood Banks
  • Clinics
  • Homecare Settings
  • Diagnostic Centers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Medical Fluid Bags Market By Product, By Material, By End-Use and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Medical Fluid Bags Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Medical Fluid Bags Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.  Global Medical Fluid Bags Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Global Medical Fluid Bags Market, By Product Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Blood Bags
        2. Intravenous Bags
        3. Drain Bags
         3.1. Surgical
         3.2. Urinary
        4. Enema Bags
        5. Biohazard Disposable Bags
        6. Breast Milk Bags
        7. Reagent Bags
        8. Dialysis Bags
        9. Others

  • 8.   Global Medical Fluid Bags Market, By Material Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. PVC Compounds
        2. Polyolefins
        3. Thermoplastic Elastomers
        4. Thermoplastic Polyurethanes
        5. Others

  • 9.   Global Medical Fluid Bags Market, By End-Use Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Hospital
        2. Blood Banks
        3. Clinics
        4. Homecare Settings
        5. Diagnostic Centers
        6. Others

  • 10.   North America Medical Fluid Bags Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2026-2036

  • 11.   Latin America Medical Fluid Bags Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2026-2036

  • 12.   Europe Medical Fluid Bags Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2026-2036

  • 13.   Asia Pacific Medical Fluid Bags Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2026-2036

  • 14.   Middle East and Africa Medical Fluid Bags Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2026-2036

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. B. Braun Medical
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Baxter International
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. C.R. Bard (Becton, Dickinson and Company)
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Coloplast
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. ConvaTec
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Fresenius Kabi
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Maco Pharma
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Pall Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Renolit
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Smiths Medical
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Technoflex
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Terumo Corporation
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Thermo Fisher Scientific
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients